Multiplex Assay Kit for Ceruloplasmin (CP) ,etc. by FLIA (Flow Luminescence Immunoassay)

CP2; CER; Caeruloplasmin; Ferroxidase; Oxygen Oxidoreductase

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Ceruloplasmin (CP) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Ceruloplasmin (CP) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Ceruloplasmin (CP) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Ceruloplasmin (CP) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-105 85
EDTA plasma(n=5) 93-105 101
heparin plasma(n=5) 78-89 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Ceruloplasmin (CP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Ceruloplasmin (CP) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Ceruloplasmin (CP) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 88-98% 84-91% 79-91% 87-104%
EDTA plasma(n=5) 92-101% 98-105% 84-98% 78-102%
heparin plasma(n=5) 88-96% 89-102% 78-92% 91-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CP) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Chinese Medical Journal Screening disease-associated proteins from sera of patients with rheumatoid arthritis: a comparative proteomic study PubMed: 20367977
Electroanalysis Electrochemical Magnetic Immunosensors for the Determination of Ceruloplasmin Onlinelibrary: elan.201300269
Talanta Amperometric immunosensor for the determination of ceruloplasmin in human serum and urine based on covalent binding to carbon nanotubes-modified screen-printed electrodes. Pubmed: 24274271
Clin Exp Nephrol. Exploring urinary biomarkers in autosomal dominant polycystic kidney disease Pubmed:25543187
PLoS One Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis PubMed: 25789864
Journal of Clinical Medicine Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese Patients Pubmed: 30486327
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA909Hu01 Recombinant Ceruloplasmin (CP) Positive Control; Immunogen; SDS-PAGE; WB.
PAA909Hu01 Polyclonal Antibody to Ceruloplasmin (CP) WB; IHC; ICC; IP.
LAA909Hu71 Biotin-Linked Polyclonal Antibody to Ceruloplasmin (CP) WB; IHC; ICC.
MAA909Hu22 Monoclonal Antibody to Ceruloplasmin (CP) WB,IHC
MAA909Hu21 Monoclonal Antibody to Ceruloplasmin (CP) WB; IHC
MAA909Hu27 Monoclonal Antibody to Ceruloplasmin (CP) WB; IHC; ICC; IP.
MAA909Hu25 Monoclonal Antibody to Ceruloplasmin (CP) WB; IHC; ICC; IP.
MAA909Hu24 Monoclonal Antibody to Ceruloplasmin (CP) WB; IHC
MAA909Hu23 Monoclonal Antibody to Ceruloplasmin (CP) WB; IHC; ICC; IP.
WEA909Hu Wide-range ELISA Kit for Ceruloplasmin (CP) Enzyme-linked immunosorbent assay for Antigen Detection.
SEA909Hu ELISA Kit for Ceruloplasmin (CP) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA909Hu CLIA Kit for Ceruloplasmin (CP) Chemiluminescent immunoassay for Antigen Detection.
LMA909Hu Multiplex Assay Kit for Ceruloplasmin (CP) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
KSA909Hu01 ELISA Kit DIY Materials for Ceruloplasmin (CP) Main materials for "Do It (ELISA Kit) Yourself".